1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands

摘要

The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.